Checkpoint Capital L.P. Portfolio Holdings
Checkpoint Capital L.P.
- $166 Billion
- Q2 2024
Checkpoint Capital L.P. has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $166 Billion distributed in 16 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Rhythm Pharmaceuticals, Inc. with a value of $37.9B, Argenx Se with a value of $35.3B, Axsome Therapeutics, Inc. with a value of $23.4B, Avadel Pharmaceuticals PLC with a value of $16B, and Protagonist Therapeutics, Inc with a value of $12.3B.
Examining the 13F form we can see an increase of $16.3B in the current position value, from $150B to 166B.
Checkpoint Capital L.P. is based out at San Francisco, CA
Below you can find more details about Checkpoint Capital L.P. portfolio as well as his latest detailed transactions.